ArticleCancer immunology, immunotherapy : CII2016

Favorable prognostic influence of T-box transcription factor Eomesodermin in metastatic renal cell cancer patients.

Anastasia Dielmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.